Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  GenMark Diagnostics, Inc    GNMK

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Nasdaq
11/15/2017 11/16/2017 11/17/2017 11/20/2017 Date
4.86(c) 4.8(c) 4.77(c) 4.64(c) 4.64 Last
826 767 828 792 415 855 698 430 698 430 Volume
+3.18% -1.23% -0.63% -2.73% -2.73% Change
More quotes
Financials ($)
Sales 2017 51,7 M
EBIT 2017 -57,7 M
Net income 2017 -60,6 M
Finance 2017 31,0 M
Yield 2017 -
Sales 2018 70,7 M
EBIT 2018 -46,4 M
Net income 2018 -49,5 M
Debt 2018 12,0 M
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018
EV / Sales2017 4,32x
EV / Sales2018 3,77x
Capitalization 254 M
More Financials
Company
GenMark Diagnostics, Inc. is a molecular diagnostics company.The firm focuses on the development and commercializing of its its proprietary eSensor detection technology.It also manufactures, sells, and supports instruments and molecular tests.The company was founded by Jon Faiz Kayyem on February... 
More about the company
Surperformance© ratings of GenMark Diagnostics, Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on GENMARK DIAGNOSTICS, INC
11/14 GNMK Law Offices of Howard G. Smith Continues Investigation on Behalf of GenM..
11/10 GLANCY PRONGAY & MURRAY LLP : Continues Investigation on Behalf of GenMark Diagn..
11/08 GNMK Law Offices of Howard G. Smith Commences Investigation on Behalf of GenM..
11/08 GENMARK DIAGNOSTICS : to Present at the Canaccord Genuity Medical Technologies &..
11/07 GENMARK DIAGNOSTICS, INC : Bronstein, Gewirtz & Grossman, LLC Announces Investig..
11/03 GLANCY PRONGAY & MURRAY LLP : Commences Investigation on Behalf of GenMark Diagn..
11/03 Pomerantz Law Firm Investigates Claims On Behalf of Investors of GenMark Diag..
11/03 Bronstein, Gewirtz & Grossman, LLC Announces Investigation of GenMark Diagnos..
11/03 Rosen Law Firm Announces Investigation of Securities Claims Against GenMark D..
11/02 GENMARK DIAGNOSTICS : reports 3Q loss
More news
Sector news : Advanced Medical Equipment & Technology - NEC
11/13 SONOVA : misses sales, profit forecasts as U.S. overhaul bites
11/12 FISHER & PAYKEL HEALTHCARE : & Paykel says UK court rules rival Resmed's patent ..
10/30DJROYAL PHILIPS : Correction to Philips Share Buyback Article
10/30DJROYAL PHILIPS : Philips Launches EUR150 Million Share Buyback for Employee Stock..
10/23 European stocks hold firm as banks, Spanish shares fall
More sector news : Advanced Medical Equipment & Technology - NEC
News from SeekingAlpha
11/16 YOUR DAILY PHARMA SCOOP : A Look At Sanofi, Ultragenyx Gets FDA Nod, Capricor Tu..
11/07 YOUR DAILY PHARMA SCOOP : Anxious Time For Dynavax Longs, VBL Therapeutics Gets ..
11/06 YOUR DAILY PHARMA SCOOP : Progenics Looks Promising, Big Week For Dynavax, Keryx..
11/06 HEALTHCARE - TOP 5 GAINERS / LOSERS : 00 am
11/03 Midday Gainers / Losers
Chart GENMARK DIAGNOSTICS, INC
Duration : Period :
GenMark Diagnostics, Inc Technical Analysis Chart | GNMK | US3723091043 | 4-Traders
Technical analysis trends GENMARK DIAGNOSTICS, INC
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 8
Average target price 11,0 $
Spread / Average Target 137%
EPS Revisions
Managers
NameTitle
Hany Massarany President, Chief Executive Officer & Director
James Charles Fox Chairman
Brian Mitchell Senior Vice President-Operations
Scott Mendel CFO & Principal Accounting Office
Jon Faiz Kayyem Senior Vice President-Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
GENMARK DIAGNOSTICS, INC-62.09%254
THERMO FISHER SCIENTIFIC INC.34.78%75 857
DANAHER19.86%64 900
INTUITIVE SURGICAL85.67%43 977
BOSTON SCIENTIFIC CORPORATION30.65%38 807
ROYAL PHILIPS14.34%36 778